Calimmune's Convertible Note Round

Calimmune raised a round of funding on September 16, 2011.

Calimmune is a clinical-stage biotechnology company focused on developing novel gene therapies that have the potential to improve and protect the lives of patients by enhancing their immune systems. C…

Articles about Calimmune's Convertible Note Round: